Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001181431-13-039210
Filing Date
2013-07-08
Accepted
2013-07-08 19:04:30
Documents
1
Period of Report
2013-07-02

Document Format Files

Seq Description Document Type Size
1 FORM 4/A rrd385526.html 4/A  
1 FORM 4/A rrd385526.xml 4/A 16113
  Complete submission text file 0001181431-13-039210.txt   18134
Mailing Address 1134 KLINE STREET LA JOLLA CA 92037
Business Address 1134 KLINE STREET LA JOLLA CA 92037 858-348-2180
Avalon Ventures IX, L.P. (Reporting) CIK: 0001493612 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-35952 | Film No.: 13958398

Mailing Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103
Business Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103 913.951.2130
ARATANA THERAPEUTICS, INC. (Issuer) CIK: 0001509190 (see all company filings)

EIN.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1134 KLINE ST LA JOLLA CA 92037
Business Address 1134 KLINE ST LA JOLLA CA 92037 858-348-2179
Avalon Ventures IX GP, LLC (Reporting) CIK: 0001578781 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-35952 | Film No.: 13958397